Alpine Bank Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111K Buy
+585
New +$101K 0.01% 208
2025
Q4
Sell
-585
Closed -$84.5K 270
2025
Q3
$84.5K Hold
585
0.01% 210
2025
Q2
$74K Hold
585
0.01% 216
2025
Q1
$74.8K Buy
+585
New +$79.3K 0.01% 203
2024
Q3
$85.2K Buy
+585
New +$84.6K 0.01% 200

Other funds holding IBB

Alpine Bank Wealth Management's IBB Position: Q2 2026 in Review

Alpine Bank Wealth Management opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 585 shares worth $111K. The stake represents 0.01% of the portfolio and ranks #208 among its holdings. This is a return to the name: Alpine Bank Wealth Management previously reported a position in IBB as recently as Q3 2025.

Alpine Bank Wealth Management first reported a position in IBB in Q3 2024 and has held it in 5 quarters since. 602 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Alpine Bank Wealth Management held 585 shares of iShares Biotechnology ETF worth $111K as of Q2 2026.
  • iShares Biotechnology ETF was a new Alpine Bank Wealth Management position in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #208 holding.
  • Alpine Bank Wealth Management first reported a position in iShares Biotechnology ETF in Q3 2024 and has held it in 5 quarters since.
  • 602 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.